Literature DB >> 9201311

Differential immunological aberrations in patients with primary and secondary Sjögren's syndrome.

U Kroneld1, A K Halse, R Jonsson, T Bremell, A Tarkowski, H Carlsten.   

Abstract

The aim of the present study was to analyse possible differences in immunological features between patients with primary and secondary Sjögren's syndrome (SS). Ten patients with primary SS and 10 patients with secondary SS also suffering from rheumatoid arthritis, were identified according to established criteria for SS. Ten healthy, age-matched women served as controls. The authors analysed the phenotypic characteristics of lymphocytes in peripheral blood as well as in focal inflammatory infiltrates of minor salivary gland biopsies. Functional analyses of T lymphocytes were performed after stimulation with mitogens and antigen. B cell activity was determined at the single cell level by spontaneous and mitogen induced immunoglobulin production. Serum levels of IL-4, IL-6 and IFN-gamma were also analysed. Patients with primary SS displayed a significantly higher degree of salivary gland inflammation and reduced salivary flow than did patients with secondary SS. Decreased in vitro T cell responses to antigen and mitogens were evident in both patient groups. The CD4/CD8 ratios in both peripheral blood and salivary gland lesions were significantly lower in primary SS compared with secondary SS patients. Polyclonal B cell activation, measured as the frequency of spontaneous immunoglobulin producing cells, was most prominent in primary SS, whereas a diminished response to poke-weed mitogen (PWM), a T cell dependent B cell mitogen, was more pronounced in secondary SS. The results reveal certain immunological aberrations in the whole group of patients with SS. In addition, the authors demonstrated distinct differences in immune dysfunction between patients with primary and secondary SS, indicating that they may constitute separate entities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201311     DOI: 10.1046/j.1365-3083.1997.d01-449.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.

Authors:  E Theander; G Henriksson; O Ljungberg; T Mandl; R Manthorpe; L T H Jacobsson
Journal:  Ann Rheum Dis       Date:  2005-11-10       Impact factor: 19.103

2.  Loss of PKCδ results in characteristics of Sjögren's syndrome including salivary gland dysfunction.

Authors:  G P Banninger; S Cha; M S Said; K M Pauley; C J Carter; M Onate; B A Pauley; S M Anderson; M E Reyland
Journal:  Oral Dis       Date:  2011-06-27       Impact factor: 3.511

3.  Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.

Authors:  Mikihito Kajiya; Isao Ichimonji; Christine Min; Tongbo Zhu; Jun-O Jin; Qing Yu; Soulafa A Almazrooa; Seunghee Cha; Toshihisa Kawai
Journal:  Mol Pharmacol       Date:  2012-04-17       Impact factor: 4.436

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.